TL;DR
This study reveals how BCG vaccination induces lasting changes in DNA methylation, acting as an "epigenetic memory" that influences how our immune system responds to subsequent challenges. These long-term methylation shifts are crucial for mediating heterologous cytokine responses, offering new avenues for developing personalized, epigenetic-based medical interventions.
What Problem Does This Paper Address?
The immune system's ability to "remember" past encounters, known as immunological memory, is fundamental to vaccination and fighting off infections. While adaptive immunity's memory is well-understood, recent research has highlighted "trained immunity" – a form of innate immune memory that can be induced by vaccines like BCG. This trained immunity involves epigenetic reprogramming, but the specific role of dynamic DNA methylation changes in shaping these long-term immune responses after BCG vaccination remained unclear. This paper aims to fill that gap by comprehensively profiling DNA methylation and cytokine responses over time to understand how BCG vaccination leaves a lasting epigenetic mark that influences future immune reactions.
Methods
The researchers employed a multi-omics approach, integrating genome-wide DNA methylation profiling with ex vivo cytokine production assays.
- DNA Methylation Profiling: They used the Infinium MethylationEPIC array to measure DNA methylation across hundreds of thousands of CpG sites in blood samples.
- Cytokine Response Assays: Peripheral blood mononuclear cells (PBMCs) were stimulated with Staphylococcus aureus (a heterologous pathogen) to measure the production of key cytokines (TNF-α, IL-1β, IL-6, and IFN-γ). The "trained immunity response" was quantified as the fold change in cytokine production from baseline to 90 days post-vaccination.
- Statistical Analysis: A mixed-effects model was used to assess dynamic DNA methylation changes over time, accounting for covariates like age and sex. Epigenome-wide association studies (EWAS) were performed to link DNA methylation patterns with cytokine responses.
- Integrative Analysis: Mediation analysis was employed to investigate the causal relationships between genetic variants, DNA methylation changes, and cytokine responses.
- Functional Enrichment: Pathway analysis tools (CPDB, eFORGE) were used to identify biological processes and functions associated with the identified CpG sites.
- Experimental Validation: The immunomodulatory role of kisspeptin on IFN-γ production was validated through in vitro experiments.
Datasets
- Discovery Cohort (300BCG): This study involved 284 healthy Dutch individuals who received BCG vaccination. Blood samples were collected at three time points: baseline (T0), 14 days post-vaccination (T14), and 90 days post-vaccination (T90). DNA methylation and ex vivo cytokine responses were measured.
- Replication Cohort: A smaller cohort of 17 individuals from a BCG booster trial was used to validate specific findings, particularly female-specific associations.
Key Insights and Ideas
- Long-Term Epigenetic Memory: BCG vaccination induces lasting changes in DNA methylation that persist for at least three months, suggesting a form of "epigenetic memory" that primes the immune system.
- Kisspeptin as a Modulator: The kisspeptin receptor system pathway emerged as a key player, with kisspeptin experimentally shown to inhibit IFN-γ production, highlighting a novel mechanism by which DNA methylation might influence immune responses.
- Sex-Specific Epigenetic Signatures: BCG vaccination elicits distinct DNA methylation changes and cytokine responses in males and females, underscoring the need to consider sex as a critical factor in immune studies and vaccine development.
- Baseline Methylation Predicts Response: Pre-existing DNA methylation patterns at specific CpG sites can predict the magnitude of the trained immunity response (specifically IFN-γ production), suggesting that individual epigenetic landscapes influence vaccine efficacy.
- Genetic Variants and Methylation Interplay: DNA methylation changes act as mediators, bridging the gap between genetic variations and heterologous cytokine responses, revealing a complex interplay in immune regulation.
Key Results
- Dynamic Methylation Changes: 11 CpG sites showed significant DNA methylation changes at 90 days post-vaccination. Short-term (T14-T0) and long-term (T90-T0) changes revealed distinct patterns, with some sites showing a "late" epigenetic effect.
- Association with Trained Immunity: 41 baseline CpG sites were significantly associated with increased IFN-γ production capacity (trained immunity). Long-term DNA methylation changes (T90-T0) were associated with trained immunity for all four measured cytokines (TNF-α, IFN-γ, IL-1β, IL-6).
- Sex-Specific Changes: Short-term methylation changes showed significant differences between males and females, with distinct pathways enriched for each sex (e.g., GnRH pathway in females, nervous system functions in males). Long-term changes also exhibited sex-specific patterns and pathway enrichments.
- Mediation Effects: Bidirectional mediation analysis identified that DNA methylation changes can mediate the effect of genetic variants on cytokine responses, particularly for IFN-γ. For example, cg21375332 near SLC12A3 mediated the effect of a genetic variant on IFN-γ changes.
- Kisspeptin Inhibition: In vitro experiments confirmed that kisspeptin significantly inhibited IFN-γ production by human PBMCs.
Limitations and Future Work
- Whole Blood Samples: DNA methylation is cell-type specific, and using whole blood samples might mask cell-type specific changes. Future studies could employ single-cell methylation analysis.
- Limited Genome Coverage: The EPIC array covers only ~3% of CpG sites in the genome. Whole-genome bisulfite sequencing would provide a more comprehensive view.
- Small Replication Cohort: The replication study had limited statistical power due to a small sample size, particularly for males, necessitating further validation.
- Lack of Non-Vaccinated Control: While the study design accounts for time-dependent changes, the absence of a non-vaccinated control group makes it harder to definitively attribute all observed changes solely to BCG vaccination.
- Transcription Level Data: The study did not assess gene expression, limiting the direct interpretation of how methylation changes translate to functional outcomes. Future work could integrate transcriptomic data.
- Functional Studies: While some in vitro validation was performed, further functional studies are needed to fully elucidate the molecular mechanisms.
- Generalizability: The study population was primarily young adults. Further research is needed to understand methylation patterns and BCG effects in older populations.
Summary updated